Neimeth International Pharmaceuticals Plc.

RC. 1557

Plot 16, Akanni Doherty Layout (Billings Way), P.M.B. 21111, Oregun Ind. Estate, Oregun, Ikeja, Lagos State, Nigeria.

Telephone: +234814 024 6475, +234 808 846 8972, +234 903 254 3202. e-mail:info@neimethplc.com.ng

www.neimethplc.com.ng

ISO 14001 : 2015

NATIONAL CERTIFICATION

CERTIFIED COMPANY SCHEME

Certificate No: 0000296 / 0000024

Lagos, Nigeria, 26th March 2024

NEIMETH INTERNATIONAL PHARMACEUTICALS PLC - NOTICE OF OUTCOME OF BOARD MEETING

Neimeth International Pharmaceuticals Plc. (the Company) wishes to inform Nigerian Exchange Limited (NGX) and the investing public that at the Board of Directors meeting held on Monday, 25th March 2024, the Board approved the Company's Audited Financial Statements for the year ended 31st December 2023 and same will be filed on or before the due date of 30th March 2024.

The Closed Period earlier announced on the trading in the Company's shares by Insiders and connected persons shall remain until 24 hours after the release of the Audited Financial Statements for 2023 to the market.

Thank you.

CHINENYE S. ADEKANMBI Ag. Company Secretary

Pleasant Fragrance.

Effectively kills 99.99% of Bacteria and

Viruses on Surfaces and Environments.

Non-Bleach.

No-Stain.

Board of Directors:

Dr. A.B.C. Orjiako (Chairman), J. Valentine C. Okelu (MD/CEO), Mazi Sam I. Ohuabunwa (OFR), Prof. Maurice M. Iwu,

Sir Ike T. Onyechi, Dr. Olusegun E. Akanji, Mr. Thomas T. Osobu, Dr. (Mrs.) Atinuke R. Uwajeh, Pharm. Roseline A. Oputa (Exec.)

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Neimeth International Pharmaceuticals plc published this content on 27 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2024 08:44:05 UTC.